MedPath

EMORY UNIVERSITY

EMORY UNIVERSITY logo
🇺🇸United States
Ownership
Private
Established
1836-12-10
Employees
10K
Market Cap
-
Website
http://www.emory.edu

National Wilm's Tumor Study Late Effects

Not Applicable
Withdrawn
Conditions
Wilm's Tumor
Interventions
Other: none, screening only
First Posted Date
2005-09-29
Last Posted Date
2013-11-26
Lead Sponsor
Emory University
Registration Number
NCT00228696
Locations
🇺🇸

Children's Healthcare of Atlanta, Atlanta, Georgia, United States

G-CSF PMRD: Granulocyte Colony Stimulating Factor (G-CSF) Stimulated Bone Marrow and In Vivo T-Cell Depletion in Patients With Hematologic Malignancies or Bone Marrow Failure Syndrome

Not Applicable
Terminated
Conditions
Hematologic Malignancies
Interventions
First Posted Date
2005-09-29
Last Posted Date
2017-09-11
Lead Sponsor
Emory University
Target Recruit Count
8
Registration Number
NCT00228813
Locations
🇺🇸

Children's Healthcare of Atlanta/Emory University, Atlanta, Georgia, United States

Hepatoblastoma Biology Study and Tissue Bank

Not Applicable
Withdrawn
Conditions
Hepatoblastoma
First Posted Date
2005-09-29
Last Posted Date
2013-11-26
Lead Sponsor
Emory University
Registration Number
NCT00228683
Locations
🇺🇸

Children's Healthcare of Atlanta, Atlanta, Georgia, United States

Effect of Sulfur Amino Acid Depletion and Acetaminophen on Plasma Glutatione

Completed
Conditions
Healthy
First Posted Date
2005-09-29
Last Posted Date
2009-01-30
Lead Sponsor
Emory University
Target Recruit Count
15
Registration Number
NCT00228644
Locations
🇺🇸

Emory University Hospital, Atlanta, Georgia, United States

Dietary Effects of Sulfur Amino Acids

Completed
Conditions
Healthy
First Posted Date
2005-09-29
Last Posted Date
2009-01-30
Lead Sponsor
Emory University
Target Recruit Count
20
Registration Number
NCT00228618
Locations
🇺🇸

Emory University Hospital, Atlanta, Georgia, United States

GVH 022P: Study Using Anti Tumor Necrosis Factor Antibody (Infliximab) for Treatment of Acute Graft Versus Host Disease

Phase 1
Completed
Conditions
Graft vs Host Disease
First Posted Date
2005-09-29
Last Posted Date
2009-06-30
Lead Sponsor
Emory University
Registration Number
NCT00228839
Locations
🇺🇸

Children's Healthcare of Atlanta/Emory University, Atlanta, Georgia, United States

IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell Immunodeficiency

Phase 1
Completed
Conditions
T-Cell Immune Deficiency Diseases
Severe Combined Immunodeficiency
First Posted Date
2005-09-29
Last Posted Date
2009-06-30
Lead Sponsor
Emory University
Registration Number
NCT00228852
Locations
🇺🇸

Children's Healthcare of Atlanta, Atlanta, Georgia, United States

Analysis of T-Cell Immune Reconstitution Following Allogeneic Hematopoietic BMT for Severe SCD

Completed
Conditions
Sickle Cell Disease
First Posted Date
2005-09-29
Last Posted Date
2014-05-26
Lead Sponsor
Emory University
Target Recruit Count
7
Registration Number
NCT00228631
Locations
🇺🇸

Children's Healthcare of Atlanta, Atlanta, Georgia, United States

Herpesvirus in Idiopathic Pulmonary Fibrosis

Completed
Conditions
Herpesvirus Infections
Lung Diseases
First Posted Date
2005-09-29
Last Posted Date
2017-05-11
Lead Sponsor
Emory University
Target Recruit Count
41
Registration Number
NCT00228670
Locations
🇺🇸

Emory University, Atlanta, Georgia, United States

The Effects of Cool Dialysate on the Sleep/Wake Cycle in Patients on Chronic Hemodialysis - "The Sleep Cool Study"

Not Applicable
Completed
Conditions
End-stage Renal Disease
Interventions
Procedure: Cool Dialysate
First Posted Date
2005-09-22
Last Posted Date
2014-02-12
Lead Sponsor
Emory University
Target Recruit Count
58
Registration Number
NCT00218790
Locations
🇺🇸

Emory affiliated hemodialysis units, Atlanta, Georgia, United States

🇺🇸

Emory University affiliated hemodialysis units, Atlanta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath